CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Prion Diseases

  • Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity📎

    Abstract Title:

    Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.

    Abstract Source:

    J Neurosci. 2007 Sep 5 ;27(36):9537-44. PMID: 17804615

    Abstract Author(s):

    Sevda Dirikoc, Suzette A Priola, Mathieu Marella, Nicole Zsürger, Joëlle Chabry

    Article Affiliation:

    Sevda Dirikoc

    Abstract:

    Prion diseases are transmissible neurodegenerative disorders characterized by the accumulation in the CNS of the protease-resistant prion protein (PrPres), a structurally misfolded isoform of its physiological counterpart PrPsen. Both neuropathogenesis and prion infectivity are related to PrPres formation. Here, we report that the nonpsychoactive cannabis constituent cannabidiol (CBD) inhibited PrPres accumulation in both mouse and sheep scrapie-infected cells, whereas other structurally related cannabinoid analogs were either weak inhibitors or noninhibitory. Moreover, after intraperitoneal infection with murine scrapie, peripheral injection of CBD limited cerebral accumulation of PrPres and significantly increased the survival time of infected mice. Mechanistically, CBD did not appear to inhibit PrPres accumulation via direct interactions with PrP, destabilization of PrPres aggregates, or alteration of the expression level or subcellular localization of PrPsen. However, CBD did inhibit the neurotoxic effects of PrPres and affected PrPres-induced microglial cell migration in a concentration-dependent manner. Our results suggest that CBD may protect neurons against the multiple molecular and cellular factors involved in the different steps of the neurodegenerative process, which takes place during prion infection. When combined with its ability to target the brain and its lack of toxic side effects, CBD may represent a promising new anti-prion drug.

  • Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders. 📎

    Abstract Title:

    Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders.

    Abstract Source:

    Oxid Med Cell Longev. 2018 ;2018:6241017. Epub 2018 Jun 27. PMID: 30050657

    Abstract Author(s):

    Adaze Bijou Enogieru, William Haylett, Donavon Charles Hiss, Soraya Bardien, Okobi Eko Ekpo

    Article Affiliation:

    Adaze Bijou Enogieru

    Abstract:

    A wide range of neurodegenerative diseases (NDs), including Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases, share common mechanisms such as neuronal loss, apoptosis, mitochondrial dysfunction, oxidative stress, and inflammation. Intervention strategies using plant-derived bioactive compounds have been offered as a form of treatment for these debilitating conditions, as there are currently no remedies to prevent, reverse, or halt the progression of neuronal loss. Rutin, a glycoside of the flavonoid quercetin, is found in many plants and fruits, especially buckwheat, apricots, cherries, grapes, grapefruit, plums, and oranges. Pharmacological studies have reported the beneficial effects of rutin in many disease conditions, and its therapeutic potential in several models of NDs has created considerable excitement. Here, we have summarized the current knowledge on the neuroprotective mechanisms of rutin in various experimental models of NDs. The mechanisms of action reviewed in this article include reduction of proinflammatory cytokines, improved antioxidant enzyme activities, activation of the mitogen-activated protein kinase cascade, downregulation of mRNA expression of PD-linked and proapoptotic genes, upregulation of the ion transport and antiapoptotic genes, and restoration of the activities of mitochondrial complex enzymes. Taken together, these findings suggest that rutin may be a promising neuroprotective compound for the treatment of NDs.